United States · Biotechnology startup
United States · Volastra Therapeutics
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Funding reportedLast round: Undisclosed round
What company datasets say Volastra Therapeutics raised
Funding, as reported
Reported in all$119Min dollars
Rounds4
Last roundUndisclosed round
Last round dateMay 2024
Investors listed11
SEC Form D$105M sold, 3 filings, last Sept 2025
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Volastra Therapeutics in front of investors. Or tell us what we have wrong.